Financial News
Headline News about Revance Therapeutics
![](https://cdn.benzinga.com/files/images/story/2023/12/12/botox-photo_by_anva_marketing_via_pexels.jpg?width=1200&height=800&fit=crop)
Botox And Similar Injections Have Associated Risks: Consumer Group Pushes for Stronger Warnings
December 12, 2023
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
What 10 Analyst Ratings Have To Say About Revance Therapeutics
November 22, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/11/09/amc_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Revance Therapeutics: Q3 Earnings Insights
November 08, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Revance Therapeutics's Earnings Outlook
November 07, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/11/09/image26.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Revance Therapeutics
November 06, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Analyst Ratings for Revance Therapeutics
October 11, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/09/20/rvnc.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/20/pinterest-_logo.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Revance Therapeutics
September 20, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/09/19/rvnc.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Where Revance Therapeutics Stands With Analysts
August 09, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/09/20/image13.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/20/instacart_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/19/autozone_-_logo_0.jpg?width=1200&height=800&fit=crop)
Dow Falls 150 Points; AutoZone Earnings Top Views
September 19, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/09/19/image14_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/19/crude_oil_6-_logo.jpg?width=1200&height=800&fit=crop)
Crude Oil Rises Over 1%; Revance Therapeutics Shares Plummet
September 19, 2023
Via Benzinga
Topics
Stocks
![](/next-assets/images/schema-image-default.png)
Earnings Preview: Revance Therapeutics
August 07, 2023
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2017/10/stock-biotech-03-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/19/image21.jpg?width=1200&height=800&fit=crop)
Markets Open Lower; US Housing Starts Fall In August
September 19, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/08/healthcare1600a.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Thursday
September 07, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/10/droplet-test-tube-biotech-1600-3.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/pill-bottle-biopharma-biotech-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2023
August 16, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.